@Sinoboy, I give you a simple example. You see, now glove sector is the most hot counter. You simply compare the Harta latest QR. Both Harta and Bursa is firmly earning money for next few quarter, then your compare their EPS, Harta 6.5sen compare to Bursa 10.7. Next you compare their dividend yield, let say Harta annual dividend at 10sen and Bursa estimated at 40sen this year, that's so much different.

@Sinoboy no one knows, Q3 yet to finalised lol... all I know is Q3 clearing fees as of today has achieve more than 58% of Q2 and we still have 37days to go lol...

Bursa's revenue is transparent and easy countable. Average 5bil adv = circa RM2mil clearing fees revenue.

We want record value hahaa... KLCI up or down, as long as clearing fees go in Bursa's pocket.

BI proposed exdate 7/9, listing 8/9

Sterile glove has higher price compare to non-sterile nitrile glove. Hospital always mark up at a premium price. Supermax sterile latex glove selling at $112 for 200 pairs at market.

Most probably CIMB projected that the share of profit of associated companies 0.5% greater than tax and interest?

Yes 28.2% for FY2020, 49% for FY2021 in the report.

Possible another record high as 3 out of top 4 glove maker going to announce quarter report; Dufu and Penta BI completed, affordable price potentially rolling high transaction value.

Estimated RM46-50mil clearing fees collected MTD July, two more month to go for Q3.

Thanks Bioalpha for promoting tiger milk mushroom to China.

Volume suddenly surging prior to closing on Thursday.. Good result? Suppose during MCO, all kedai runcit sales flying high, people no intent to go crowd retailer.

Sometimes I need to admit FA is worth nothing in share market, price can be goreng up more than 100% of the company's worth.

I recall HLRI never posted net profit since acquired until now? Even during the covid-19 breakout in Taiwan last quarter?

Q2 result just mark the start of high adv trading, more to come in near future especially on tech and healthcare sectors with hope of consumption sector to return. In fact, the total daily trade value of all the participants have at least doubled in June compared to January not only the local retailer.

@freetospeak, haha up to them lah... No idea why been smashed, I owned Supermax too and I believe it can go above 20. I just told them the reality is RM1bil PAT cannot be achieve with current asp, it need to go above $200 with assumption of 100% utilization rate.

I cannot believe that this day commented PAT below 500mil will got smashed by people here.

Go learn some consolidated reporting before you show your figure to mislead people.

This forum is getting interesting, PAT can blow until sky.

Dear, Q3 (Jan-March) OBM Asp at around $60, you may ask any sifu here or search for Supermax briefing presentation :))

Aramco Q 3 was Pre Convid 19 so price very low n competitive
No such price of USD60

My rough calculation based on asp of USD200 and assumption of 100% utilization rate got around 700mil. This is my prediction for Q1FY2021 only if Q4FY2020 projection realized.

Manufacturing 1,611,944
Trading 861,032
Elimination -1,144,879
Consolidated Revenue 1,328,097
Cost 406,519
PBT 921,578
PAT 700,399

Aggressive approach for Q4:

Manufacturing 1,345,939 (+ASP, +15% Sales volume)
Trading 614,123 (+ASP, +15% Sales volume)
Elimination -924,503
Consolidated Revenue 1,035,559
COGS 405,971 (+15% cost, could be lower)
PBT 629,588 (25% effective tax rate)
PAT 472,191

@aramco, lol.... so with your calculation method, did supermax got 1.5bil sales revenue during Q3 with asp of USD60?... lol

@Targeted, yes if 500mil is a very bombastic result, my aggressive approach around PAT 472mil, in fact any figure above 350mil consider a acceptable result for Q4.

Please don't blow too big haha

Sorry to say, 500mil PAT make sense but not 1bil lol...

https://klse.i3investor.com/entitlement/1818/28-Jul-2020/21323_1938342593.jsp

You may refer here.

Hahaha... no wonder lah... C27's exercise price RM5.85 and will be the next to expire on 30 Oct.

https://www.theedgemarkets.com/article/rhb-likely-shift-full-fy20-dividend-payout-4q-says-kenanga

I see Bursa has higher potential to be put into value investor's radar.

Many are worry the current high level of adv supported mostly by local retailer. However, foreign institutional and retailer traded value has increase almost double from RM8.1bil at January compared to RM14.6bil at June, same goes to local institutional double from RM15bil to RM30bil.

Oops accidentally deleted the y-o-y comment lol... anyhow @terence775 pointed a more details comparison :))

anything brew?

Dufu and Penta BI kick in on August and follow by TG and Supermax.

Signal of confidence.

Nice one, 6.6mil of esos at 0.205. No need to worry go back below 0.2 already, can hold long term :))

Adv for July circa RM5.45bil

Agreed with you @Brown, Bursa's performance are transparent and I like their reporting too, informative and details.

@Titan, haha... Joke only lah.. I recall are ambank and rhb? I saw it this morning from theedge, you can go have a look. Prior to qr release I also thought it's overvalued as my own TP is around 8.5-9.5, however the results exceed my earlier projection then I re-enter.

Only HLIB got guts to give TP RM11.85, other all cowards lol

Lol... 3 years go back to rm8 already lah... Current 1-2years will be max benefit. Don't forgot TG and Supermax BI soon, Q3 results will be the best of the best.

Dpharma and pharma drop significantly because Minister response yesterday that both of them are not exclusively to pack vaccine. Doesn't it a good news to bioalpha? Lol nice analysis.

But the good side is they upgrade Bursa PE ratio to 28-31 from previous 24-25.

no wonder durian runtuh la... IBs TP 9.3-9.4

what announcement? extend moratorium?

@Killsthebear, wah... you finally bought in?

This is indeed a very attractive price traded below forward PER 26, sad that doesn't have extra fund.

@terence775, revised TP? might to share the link?

1. Product mix by revenue 9M'FY2020 Nitrile PF 63%; Latex PF 20%; Latex powder 14%, Surgical glove 3%. Starting from March, ratio of Nitrile:Latex:Surgical = 83:14:3

2. Current capacity 24bil per annum, Q3 +1.1bil per annum, Q4 +1.1bil per annum.

3&4. Sales by geographical area 9M'FY20
America 51%
Europe 23%
Asia and Oceania 23%
Africa 3%

5. Hello. Can lah!

@terence775, agree with most of your point, especially the low interest-rate environment. Average historical PE at around 26x, PER 30 make sense under current financial market. Last update on trading participation, we see foreign fund is coming back, I hope this can keeping up.

https://www.bursamalaysia.com/misc/missftp/securities/securities_equities_keyindicators_2020-07-28-02-00-01.pdf

Adv of MTD July (3-market days yet to include) alone already accounted 78.5% April+May. Any chance for July to exceed Apr+May?